The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
2019 · Cancer Cell International · 8 citations
https://doi.org/10.1186/s12935-019-0807-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
555
Citations
13
h-index
14
i10-index
Susanna Grassi is an academic researcher from University of Pisa. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 13, co-authored 51 publications.
Click to start Chat